Pharmacielo Competitors

Pharmacielo (OTCMKTS:PHCEF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Pharmacielo and Abacus Health Products' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Pharmacielo and Abacus Health Products' revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Pharmacielo and Abacus Health Products, as provided by MarketBeat.com.

Acreage (OTCMKTS:ACRGF) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Acreage and Pharmacielo, as reported by MarketBeat.

Acreage currently has a consensus target price of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher possible upside, equities research analysts clearly believe Acreage is more favorable than Pharmacielo.

Profitability

This table compares Acreage and Pharmacielo's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Acreage and Pharmacielo's gross revenue, earnings per share and valuation.

Summary

Acreage beats Pharmacielo on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Applied Biosciences and Pharmacielo, as provided by MarketBeat.com.

Profitability

This table compares Applied Biosciences and Pharmacielo's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Applied Biosciences and Pharmacielo's top-line revenue, earnings per share and valuation.

Ayr Strategies (OTCMKTS:AYRSF) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Ayr Strategies and Pharmacielo, as provided by MarketBeat.com.

Ayr Strategies currently has a consensus price target of $34.8571, suggesting a potential upside of 63.96%. Given Ayr Strategies' higher probable upside, research analysts clearly believe Ayr Strategies is more favorable than Pharmacielo.

Profitability

This table compares Ayr Strategies and Pharmacielo's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Ayr Strategies and Pharmacielo's top-line revenue, earnings per share and valuation.

Summary

Ayr Strategies beats Pharmacielo on 2 of the 2 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Can B and Pharmacielo, as provided by MarketBeat.com.

Profitability

This table compares Can B and Pharmacielo's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Can B and Pharmacielo's top-line revenue, earnings per share and valuation.

Cansortium (OTCMKTS:CNTMF) and Pharmacielo (OTCMKTS:PHCEF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for Cansortium and Pharmacielo, as provided by MarketBeat.com.

Cansortium currently has a consensus price target of $1.20, suggesting a potential upside of 41.18%. Given Cansortium's higher probable upside, research analysts clearly believe Cansortium is more favorable than Pharmacielo.

Profitability

This table compares Cansortium and Pharmacielo's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Cansortium and Pharmacielo's top-line revenue, earnings per share and valuation.

Summary

Cansortium beats Pharmacielo on 2 of the 2 factors compared between the two stocks.